Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine Daily Doses for Premature Ejaculation
NCT01024491Phase 3Completed
- Sponsor
- MorePharma
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paroxetine in premature ejaculation (PE) (3 arms), sponsored by MorePharma. Primary endpoint: Intravaginal Ejaculatory Latency Time at 12 weeks. Started Aug 2008; status: completed.
02
Drugs
paroxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01024491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024491.